Simard John's Form 4 filing
XBiotech Inc. (XBIT) · filed Sep 28, 2021
- Accession no.
- 0001209191-21-057877
- Filed
- Sep 28, 2021
- Trade date
- Sep 23-27, 2021
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $753.3K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simard JohnCIK 0001639078 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | SSaleDisposed | −9,892 | $14.68 | −$145,214.56 | 4,113,274 | Direct | |
| Sep 24, 2021 | Common Stock | SSaleDisposed | −11,418 | $14.49 | −$165,446.82 | 4,101,856 | Direct | |
| Sep 27, 2021 | Common Stock | SSaleDisposed | −29,890 | $14.81 | −$442,670.9 | 4,071,966 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.